National and global factors like the Russia-Ukraine war are complicating supply chain issues in the U.S., with health systems expecting to see price hikes in certain medical supplies for which raw materials are sourced in Russia.
Millions of chronically ill patients are struggling to get medical supplies amid global shortages exacerbated by the COVID-19 pandemic, The New York Times reported March 29.
China’s lockdown of Shanghai to curb a COVID-19 outbreak has exporters bracing for delays from the supply chain disruptions, The Wall Street Journal reported March 28.
The potential strike of 22,000 dockworkers along the nation’s West Coast could aggravate current supply shortages and lead to higher prices for consumer goods, The New York Times reported March 28.
The U.S. is halting distribution of sotrovimab, a COVID-19 antibody made by GlaxoSmithKline and Vir Biotechnology, in regions where the omicron subvariant BA.2 has become dominant in response to data suggesting the treatment is ineffective against the …